China’s First Medical Devices Innovation Base To Set Up In Chongqing
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Science and Technology has reached an agreement with Chongqing municipal government to set up an independent national innovation industry base for medical devices. The facility will focus on common problems in the industry by building up a public service platform for fast innovation design, new technology development and application, as well as experimental technology standards. It will also conduct industry, national and international research. After five years, the base is targeted to achieve breakthrough in industrialized core technologies for 50 projects and realize a production value of RMB 50 billion. Chongqing has an edge in independent R&D and innovation within the digital health sector, having developed the world's first high-intensity focused ultrasound tumor therapy system and Asia's first gastrointestinal capsule endoscopy. (Click here for more - Chinese Language)
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.